AvoMed

Biowaste-based Bioactive Compound for Dermal Disorders

Health Tech & Life Sciences
Non Active, Dec 2022 ceased to operate
Seed Rosh Pinna Founded 2016
Total raised
Last: SAFE 2022-08
Stage
Seed
Founded
2016
Headcount
5
HQ
Rosh Pinna
Sector
Health Tech & Life Sciences

About

AvoMed develops and manufactures AvoMed PFA, a patented bioactive compound extracted from avocado pits (biowaste) and used as an active ingredient to enhance personal care products and treat dermal disorders such as psoriasis and atopic dermatitis. The result of over six years of product development and extensive scientific research, AvoMed PFA has demonstrated in preclinical and clinical studies its ability to repair damage to the human skin caused by UV radiation, pollution, aging, and other stressors. It has also proven effective for phospholipase A2 inhibition and other dermal inflammatory disorders.

Funding history · 1 round · — total

2022-08
SAFE Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is AvoMed's primary product?
AvoMed develops and manufactures AvoMed PFA, a patented bioactive compound extracted from avocado pits (biowaste).
What are the intended uses of AvoMed PFA?
AvoMed PFA is used as an active ingredient to enhance personal care products and treat dermal disorders such as psoriasis and atopic dermatitis.
What has AvoMed PFA demonstrated in studies?
In preclinical and clinical studies, AvoMed PFA has demonstrated its ability to repair damage to human skin caused by UV radiation, pollution, aging, and other stressors, and has proven effective for phospholipase A2 inhibition and other dermal inflammatory disorders.
When was AvoMed founded?
AvoMed was founded in June 2016.
What is the operational status of AvoMed?
AvoMed is currently inactive, having ceased to operate in December 2022.
Where is AvoMed headquartered?
AvoMed is headquartered in Rosh Pinna, Israel.
What was AvoMed's last funding round?
AvoMed's last funding round was a SAFE round in August 2022, with PipelBiz as a lead investor. For full financing history, refer to startupim.
How many employees did AvoMed have?
AvoMed had between 1 and 10 employees.
What is the primary sector of AvoMed?
AvoMed's primary sector is Health Tech & Life Sciences.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnologyCosmetics
Business model
B2B

Highlights

1 PatentsVerified

Tags

anti-aginganti-inflammatorynatural-active-ingredientsbiotechnologyhealthcare-providersmedical-technologiescosmetic-companiesskin-carecosmeticsdermatology